140 related articles for article (PubMed ID: 35372039)
1. Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer
Jiang B; Xia J; Zhou X
Front Oncol; 2022; 12():712475. PubMed ID: 35372039
[TBL] [Abstract][Full Text] [Related]
2. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p.
Xue J; Zhang Z; Li X; Ren Q; Wang Q
Oncol Lett; 2020 Feb; 19(2):1255-1260. PubMed ID: 31966055
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the subcellular location of lncRNA SLC16A1-AS1 and its interaction with premature miR-5088-5p in oral squamous cell carcinoma.
Li T; Wang D; Yang S
Odontology; 2023 Jan; 111(1):41-48. PubMed ID: 35829849
[TBL] [Abstract][Full Text] [Related]
6. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation.
Long Y; Li H; Jin Z; Zhang X
Cancer Manag Res; 2021; 13():1215-1223. PubMed ID: 33603467
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis.
Zhang H; Jin S; Ji A; Ma Y; Zhang C; Wang A; Wang R
Cancer Manag Res; 2021; 13():1299-1306. PubMed ID: 33603475
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
11. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
12. LncRNA OIP5-AS1 Upregulates the Cyclin D2 Levels to Promote Metastasis of Breast Cancer by Targeting miR-150-5p.
Wu H; Huang Q; Xu T; Zhang J; Zeng J; Wang Q; Zhang Y; Yu Z
Appl Biochem Biotechnol; 2024 Jun; ():. PubMed ID: 38888699
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression.
Feng H; Wang Q; Xiao W; Zhang B; Jin Y; Lu H
Onco Targets Ther; 2020; 13():4799-4811. PubMed ID: 32547107
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival.
Tian J; Hu D
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101490. PubMed ID: 33744723
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
Jiang B; Liu Q; Gai J; Guan J; Li Q
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
[TBL] [Abstract][Full Text] [Related]
19. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
[TBL] [Abstract][Full Text] [Related]
20. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
Yang Y; Wang F; Huang H; Zhang Y; Xie H; Men T
Onco Targets Ther; 2019; 12():1351-1358. PubMed ID: 30863101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
